Source: International Congress 2014 – ILDs: connective tissue disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Oehrle, G. Burgstaller, M. Irmler, S. Dehmel, A. Cornett, T. Hwang, J. Beckers, S. Krauss-Etschmann, E. S. White, S. Meiners, O. Eickelberg (Munich, Germany; Ann Arbor, United States Of America). Secreted frizzled-related protein 1 (Sfrp1) as key mediator of growth-factor induced invasion. Eur Respir J 2014; 44: Suppl. 58, 727

Member's Comments

No comment yet.

Related content which might interest you: Serum B cell activating factor (BAFF) as a prognostic biomarker in interstitial lung diseases associated with connective tissue diseases Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Fibroblast growth factor 9 (FGF9) modulates the phenotype of control and fibrotic human lung fibroblasts in vitro Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014 Serine and arginine-rich splicing factors as nuclear targets for TGF-beta1 Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Fibroblast heterogeneity in the diseased lung Source: International Congress 2014 – ILDs 3 Year: 2014 Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias Source: International Congress 2014 – IPF and surroundings Year: 2014 LATE-BREAKING ABSTRACT: Protein tyrosine phosphatase (PTP)alpha promotes profibrotic responses in fibroblasts via Smad signaling Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014 The enhancement of Stanniocalcin-1 (STC1) secretion increases the ability of mesenchymal stem cells (MSCs) to reduce bleomycin-induced lung fibrosis in a mouse model through inhibition of endoplasmic reticulum stress (ER-stress)/TGFbeta1 pathway Source: International Congress 2014 – ILDs 1 Year: 2014 Uncoupling the pro-fibrotic effects of TGF-beta1 versus tissue hardening in lung fibroblasts Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Endothelin-1 induced connective tissue growth factor expression in human lung fibroblasts by ETAR-dependent JNK/AP-1 pathway Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Toll like receptor 4 activation upregulates miR-181b attenuating pulmonary fibrosis via targeting TGFBR1 Source: International Congress 2015 – Latest news on miRNAs in pulmonary research Year: 2015 Low density lipoprotein receptor-related protein 1 is a novel activator of beta1 Integrin-dependent fibroblast adhesion, spreading and migration Source: International Congress 2014 – ILDs 1 Year: 2014 Collagen V overexpression correlates with IL-17+ cells in C57BL/6 mice pulmonary remodeling Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Interleukin-6 in systemic sclerosis and potential correlation with pulmonary involvement Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Ex vivo trans-differentiation of primary human alveolar epithelial cells type II by TGFb Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Elevated protein arginine methyltransferase 1 expression contributes to the pathogenesis of pulmonary fibrosis Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Differential VEGF signalling in the lung Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 IL-17+ cells immunoexpression in systemic sclerosis pulmonary fibrosis Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 LATE-BREAKING ABSTRACT: Erythropoietin (EPO) inhibits the immunohistochemical expression of Tumor Necrosis Factor-a (TNF-a) in bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats Source: International Congress 2014 – Lung cell biology in injury and repair Year: 2014 Type V collagen induced pulmonary fibrosis in C57Bl/6mice Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Pirfenidone suppresses proinflammatory and antiangiogenetic cytokine production by alveolar macrophages (AMs) in idiopathic non specific interstitial pneumonia (iNSIP) Source: International Congress 2014 – ILDs 2 Year: 2014